Scopus
EXPORT Nikolakaki E.

Leonidis G., Sigala I., Spathakis M., Kolios G., Giannakouros T., Nikolakaki E., Sarli V.
Synthesis of novel SRPK1-targeting hybrid compounds incorporating antimetabolites for cancer therapy
(2025) RSC Medicinal Chemistry, 16 (12), pp. 6285 - 6298, Cited 0 times.
DOI: 10.1039/d5md00731c

Koukiali A., Daniilidou M., Mylonis I., Giannakouros T., Nikolakaki E.
SR Protein Kinase 1 Inhibition by TAF15
(2023) Cells, 12 (1), art. no. 126, Cited 4 times.
DOI: 10.3390/cells12010126

Leonidis G., Dalezis P., Trafalis D., Beis D., Giardoglou P., Koukiali A., Sigala I., Nikolakaki E., Sarli V.
Synthesis and Biological Evaluation of a c(RGDyK) Peptide Conjugate of SRPIN803
(2021) ACS Omega, 6 (42), pp. 28379 - 28393, Cited 4 times.
DOI: 10.1021/acsomega.1c04576

Christou C., Pavlou I., Sigala I., Nikolakaki E., Hadjipavlou-Litina D.J., Litinas K.E.
Synthesis of pyridocoumarin β-glycosides with possible biological activity<sup>¶</sup>
(2023) Arkivoc, 2023 (7), art. no. 202312085, Cited 0 times.
DOI: 10.24820/ARK.5550190.P012.085

Douka M.D., Sigala I.M., Nikolakaki E., Prousis K.C., Hadjipavlou-Litina D.J., Litinas K.E.
Cu-Catalyzed Synthesis of Coumarin-1,2,3-Triazole Hybrids connected with Quinoline or Pyridine Framework**
(2024) ChemistrySelect, 9 (22), art. no. e202401957, Cited 7 times.
DOI: 10.1002/slct.202401957

Nikolakaki E., Sigala I., Giannakouros T.
Good Cop, Bad Cop: The Different Roles of SRPKs
(2022) Frontiers in Genetics, 13, art. no. 902718, Cited 19 times.
DOI: 10.3389/fgene.2022.902718

Sigala I., Koutroumani M., Koukiali A., Giannakouros T., Nikolakaki E.
Nuclear translocation of srpks is associated with 5-fu and cisplatin sensitivity in hela and t24 cells
(2021) Cells, 10 (4), art. no. 759, Cited 19 times.
DOI: 10.3390/cells10040759

Leonidis G., Koukiali A., Sigala I., Tsimaratou K., Beis D., Giannakouros T., Nikolakaki E., Sarli V.
Synthesis and Anti-Angiogenic Activity of Novel c(RGDyK) Peptide-Based JH-VII-139-1 Conjugates
(2023) Pharmaceutics, 15 (2), art. no. 381, Cited 3 times.
DOI: 10.3390/pharmaceutics15020381

Charalambous V.Y., Sigala I., Ouzounthanasis K.A., Rizos S.R., Mantzourani C., Kokotou M.G., Fylaktakidou K.C., Giannakouros T., Nikolakaki E., Koumbis A.E.
SAR studies of chabrolonaphthoquinone B via rational design and synthesis of analogues - Cytotoxicity evaluation uncovers anticancer activity via mRNA splicing modulation
(2025) European Journal of Medicinal Chemistry, 300, art. no. 118175, Cited 0 times.
DOI: 10.1016/j.ejmech.2025.118175

Douka M.D., Sigala I.M., Gabriel C., Nikolakaki E., Hadjipavlou-Litina D.J., Litinas K.E.
Pharmacochemical Studies of Synthesized Coumarin–Isoxazole–Pyridine Hybrids
(2025) Molecules, 30 (7), art. no. 1592, Cited 3 times.
DOI: 10.3390/molecules30071592

Lesgidou N., Koukiali A., Nikolakaki E., Giannakouros T., Vlassi M.
PIM-1L Kinase Binds to and Inactivates SRPK1: A Biochemical and Molecular Dynamics Study
(2025) Proteins: Structure, Function and Bioinformatics, 93 (3), pp. 629 - 653, Cited 3 times.
DOI: 10.1002/prot.26757

Sigala I., Koukiali A., Miliotou A., Lougiaki P., Giannakouros T., Nikolakaki E.
An atm/chk2 signaling pathway induces nuclear translocation of srpk2 in cisplatin-treated hela cells
(2021) Processes, 9 (12), art. no. 2223, Cited 5 times.
DOI: 10.3390/pr9122223

Tsopka I.-C., Pontiki E., Sigala I., Nikolakaki E., Prousis K.C., Hadjipavlou-Litina D.
Design, Synthesis, Biological Evaluation, and In Silico Studies of Novel Multitarget Cinnamic Acid Hybrids †
(2025) Molecules, 30 (23), art. no. 4582, Cited 0 times.
DOI: 10.3390/molecules30234582